As reported in Fig. 1a, while BCL-XL overexpressing clones show superimposable expression level of MCL-1 protein when compared to control clones, a reduced expression of BCL-2 protein was observed in both melanoma and glioblastoma models. This evidence concerns the gene MCL1 and glioblastoma.